CHA
IBB icon

Carmichael Hill & Associates’s iShares Biotechnology ETF IBB Stock Holding History

Carmichael Hill & Associates’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$79.1K Buy
543
+1
+0.2% +$145 0.03% 298
2024
Q2 		$74.4K Sell
542
-59
-10% -$7.88K 0.03% 286
2024
Q1 		$82.5K Sell
601
-7
-1% -$956 0.03% 273
2023
Q4 		$82.6K Buy
608
+209
+52% +$25.5K 0.03% 273
2023
Q3 		$48.8K Hold
399
– – 0.02% 333
2023
Q2 		$50.7K Hold
399
– – 0.02% 330
2023
Q1 		$51.6K Sell
399
-84
-17% -$11K 0.02% 318
2022
Q4 		$63.4K Buy
483
+329
+214% +$42.5K 0.03% 299
2022
Q3 		$18K Buy
154
+66
+75% +$8.2K 0.01% 491
2022
Q2 		$10K Hold
88
– – 0.01% 558
2022
Q1 		$11K Sell
88
-66
-43% -$8.6K 0.01% 589
2021
Q4 		$24K Buy
154
+70
+83% +$10.8K 0.01% 495
2021
Q3 		$14K Hold
84
– – 0.01% 554
2021
Q2 		$14K Hold
84
– – 0.01% 554
2021
Q1 		$13K Hold
84
– – 0.01% 555
2020
Q4 		$13K Hold
84
– – 0.01% 532
2020
Q3 		$11K Hold
84
– – 0.01% 513
2020
Q2 		$11K Hold
84
– – 0.01% 487
2020
Q1 		$9K Hold
84
– – 0.01% 473
2019
Q4 		$10K Buy
+84
New +$9.37K 0.01% 484

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Carmichael Hill & Associates's IBB Position: Q3 2024 in Review

Carmichael Hill & Associates increased its iShares Biotechnology ETF (IBB) stake by 0.18% in Q3 2024, buying an estimated $145 and bringing the position to 543 shares worth $79.1K. The position accounts for 0.03% of the portfolio, ranked #298.

Carmichael Hill & Associates first reported a position in IBB in Q4 2019 and has held it in 20 quarters since. The position peaked at $82.6K in Q4 2023. 893 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

  • Carmichael Hill & Associates held 543 shares of iShares Biotechnology ETF worth $79.1K as of Q3 2024.
  • Carmichael Hill & Associates bought 1 iShares Biotechnology ETF share in Q3 2024, an estimated $145.
  • iShares Biotechnology ETF made up 0.03% of Carmichael Hill & Associates's portfolio in Q3 2024, its #298 holding.
  • Carmichael Hill & Associates first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 20 quarters since.
  • Carmichael Hill & Associates's iShares Biotechnology ETF position peaked at $82.6K in Q4 2023.
  • 893 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.